References
- Pagano L., Lacerra G., Camardella L., De Angioletti M., Fioretti G., Maglione G., de Bonis C., Guarino E., Viola A., Cutolo R., De Rosa L., Carestia C. Hemoglobin Neapolis, β126(H4)Val→Gly: a novel β‐chain variant associated with a mild β‐thalassemia phenotype and displaying anomalous stability features. Blood 1991; 78(11)3070–3075
- Miller S. A., Dykes D. D., Polesky H. F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16(3)1215
- Lacerra G., Fioretti G., De Angioletti M., Pagano L., Guarino E., de Bonis C., Viola A., Maglione G., Scarallo A., De Rosa L., Carestia C. (α)α5.3: a novel α+‐thalassemia deletion with the breakpoints in the α2‐globin gene and in close proximity to an Alu family repeat between the ψα2‐ and ψα1‐globin genes. Blood 1991; 78(10)2740–2746
- Huisman T. H.J., Carver M. F.H., Efremov G. D. A Syllabus of Human Hemoglobin Variants Second Edition. The Sickle Cell Anemia Foundation, Augusta 1998, http://globin.cse.psu.edu
- Bunn H. F., Forget B. G. Unstable hemoglobin variants‐congenital Heinz body hemolytic anemia. Hemoglobin: Molecular, Genetic and Clinical Aspects. W.B. Saunders Company, Philadelphia 1986; 565–594
- Carrell R. W., Lehmann H., Hutchison H. E. Haemoglobin Köln (β98 Valine→ Methionine): an unstable protein causing inclusion‐body anaemia. Nature 1966; 210(39)915–916
- Orringer E. P., Felice A., Reese A., Wilson J. B., Lam H., Gravely M. E., Huisman T. H.J. Hb Nottingham (α2β298(FG5)Val→Gly) in a Caucasian male: clinical and biosynthetic studies. Hemoglobin 1978; 2(4)315–332
- Cepreganova B., Wilson J. B., Huisman T. H.J., Hume H. A. Hb Nottingham or α2β298(FG5)Val→Gly observed as a de novo mutation in a Canadian child. Hemoglobin 1992; 16(1&2)77–79
- Gacon G., Wajcman H., Labie D., Cosson A. A new unstable hemoglobin mutated in β98 (FG5) Val→Ala: Hb Djelfa. FEBS Lett 1975; 58(1)238–240
- Lacan P., Aubry M., Francina A., Couprie N., Dementhon L., Becchi M. Characterization of Hb Djelfa [β98(FG5)Val→Ala] by DNA sequencing in a French Caucasian family. Hemoglobin 1999; 23(1)73–77
- Wajcman H., Behnken L. J., Riou J., Galacteros F. Hb Mainz [β98(FG5)Val→Glu]: a new unstable variant carrying a structural modification at the same position as Hb Koln. Br J Haematol 1994; 87(suppl 1)66, (Abstract 258; 1st European Hematology Association, Bruxelles, Belgium, 1994)
- Ho P. J., Rochette J., Rees D. C., Fisher C. A., Huehns E. R., Will A. M., Thein S. L. Hb Sun Prairie: diagnostic pitfalls in thalassemic hemoglobinopathies. Hemoglobin 1996; 20(2)103–112
- Wajcman H., Vasseur C., Blouquit Y., Rosa J., Labie D., Najman A., Reman O., Leporrier M., Galacteros F. Unstable α‐chain hemoglobin variants with factitious β‐thalassemia biosynthetic ratios: Hb Questembert (α131[H14]Ser→Pro) and Hb Caen (α132[H15]Val→Gly). Am J Hematol 1993; 42(4)367–374
- Cürük M. A., Dimovski A. J., Baysal E., Gu L‐H, Kutlar F., Molchanova T. P., Webber B. B., Altay Ç, Gürgey A., Huisman T. H.J. Hb Adana or α259(E8)Gly→Aspβ2, a severely unstable α1‐globin variant, observed in combination with the ‐(α)20.5 Kb α‐thalassemia‐1 deletion in two Turkish patients. Am J Hematol 1993; 44(4)270–275
- Traeger‐Synodinos J., Metaxotou‐Mavromati A., Kanavakis E., Vrettou C., Papassotiriou I., Michael Th, Kattamis C. An α‐thalassemic hemoglobinopathy: homozygosity for the Hb Agrinio α2‐globin chain variant. Hemoglobin 1998; 22(3)209–215
- Traeger‐Synodinos J., Papassotiriou I., Metaxotou‐Mavrommati A., Vrettou C., Stamoulakatou A., Kanavakis E. Distinct phenotypic expression associated with a new hyperunstable α globin variant (Hb Heraklion, α1cd 37(C2)Pro→0): comparison to other α‐thalassemic hemoglobinopathies. Blood Cells Mol Dis 2000; 26(4)276–284
- Pobedimskaya D. D., Molchanova T. P., Streichman S., Huisman T. H.J. Compound heterozygosity for two α‐globin gene defects, Hb Taybe (α1; 38 or 39 minus Thr) and a poly A mutation (α2; AATAAA→AATAAG), results in a severe hemolytic anemia. Am J Hematol 1994; 47(3)198–202